fleroxacin has been researched along with Urethritis in 4 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Urethritis: Inflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Eighty male patients with gonococcal urethritis were randomly allocated to receive, in an open study, either a single oral 400 mg dose of fleroxacin, or, as standard therapy, a single intramuscular dose of 2." | 9.06 | Fleroxacin versus standard therapy in gonococcal urethritis. ( Ellmén, J; Lassus, A; Renkonen, OV, 1988) |
| "We performed basic and clinical studies on the effects of a new oral antimicrobial agent, fleroxacin (FLRX), a new quinolone derivative in male gonococcal urethritis." | 7.68 | [Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis]. ( Hamaya, O; Miyamura, R; Ono, K; Saito, I; Suzuki, A; Yokozawa, M, 1991) |
| "Eighty male patients with gonococcal urethritis were randomly allocated to receive, in an open study, either a single oral 400 mg dose of fleroxacin, or, as standard therapy, a single intramuscular dose of 2." | 5.06 | Fleroxacin versus standard therapy in gonococcal urethritis. ( Ellmén, J; Lassus, A; Renkonen, OV, 1988) |
| "We performed basic and clinical studies on the effects of a new oral antimicrobial agent, fleroxacin (FLRX), a new quinolone derivative in male gonococcal urethritis." | 3.68 | [Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis]. ( Hamaya, O; Miyamura, R; Ono, K; Saito, I; Suzuki, A; Yokozawa, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, I | 1 |
| Suzuki, A | 1 |
| Yokozawa, M | 1 |
| Ono, K | 1 |
| Miyamura, R | 1 |
| Hamaya, O | 1 |
| Bowie, WR | 1 |
| Willetts, V | 1 |
| Megran, DW | 1 |
| Lassus, A | 1 |
| Renkonen, OV | 1 |
| Ellmén, J | 1 |
| Pust, RA | 1 |
| Ackenheil-Köppe, HR | 1 |
| Weidner, W | 1 |
| Meier-Ewert, H | 1 |
2 trials available for fleroxacin and Urethritis
| Article | Year |
|---|---|
Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Chlamydia Infections; Chlamydia trachomatis; Ciprofl | 1989 |
Fleroxacin versus standard therapy in gonococcal urethritis.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Fleroxacin; Follow-Up Studies; Gonorrhea; Humans; Male; | 1988 |
2 other studies available for fleroxacin and Urethritis
| Article | Year |
|---|---|
[Bacteriological and clinical studies on fleroxacin in male gonococcal urethritis].
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Drug Evaluation; Drug Resistance, Micr | 1991 |
Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis.
Topics: Anti-Infective Agents; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Drug Tolerance; F | 1988 |